Open Now
Contact Information
116-30 Sutphin Boulevard , Jamaica, New York 11434, United States
Detailed Information
Queens Village Committee for MH JCAP Inc
-
Services:
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Self-help groups
- Assistance with obtaining social services
- Employment counseling or training
- Mentoring/peer support
- Housing services
- Recovery coach
- Payment assistance (check with facility for details)
- Sliding fee scale (fee is based on income and other factors)
- Treatment for other addiction disorder
- Long-term residential
- Residential/24-hour residential
- Private for-profit organization
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Cash or self-payment
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Integrated primary care services
- Social skills development
- Mental health services
- Child care for clients’ children
- Domestic violence services, including family or partner
- Case management service
- Suicide prevention services
- Transportation assistance
- Early intervention for HIV
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Adults
- Young Adults
- Substance use treatment
- Male
- Motivational interviewing
- Matrix Model
- Community reinforcement plus vouchers
- Trauma-related counseling
- Relapse prevention
- Contingency management/motivational incentives
- Cognitive behavioral therapy
- Anger management
- Brief intervention
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- 12-step facilitation
- Lofexidine
- Acamprosate (CampralĀ®)
- Medications for Hepatitis C treatment
- Disulfiram
- Buprenorphine without naloxone
- Medications for HIV treatment
- Buprenorphine with naloxone
- Medication for mental disorders
- Naltrexone (oral)
- Medications for pre-exposure to prophylaxis
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Buprenorphine sub-dermal implant
- Clonidine
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Vaping not permitted
- Group counseling
- Family counseling
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Individual counseling
- Prescribes naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Metabolic syndrome monitoring
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Breathalyzer or blood alcohol testing
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- STD testing
- TB screening
- HIV testing
- Complete medical history/physical exam
- Screening for mental disorders
- Comprehensive substance use assessment
- Screening for tobacco use
- Interim services for clients
- Outreach to persons in the community
- Comprehensive mental health assessment
- Screening for substance use
- Professional interventionist/educational consultant
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Veterans
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Seniors or older adults
- Clients who have experienced sexual abuse
- Adult men
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced intimate partner violence, domestic violence
- Clients with HIV or AIDS
- Clients with co-occurring pain and substance use disorders
- Young adults
- Spanish
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- State Substance use treatment agency
- Healthcare Facilities Accreditation Program (HFAP)
- Council on Accreditation (COA)
- State department of health
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Federally Qualified Health Center
- National Committee for Quality Assurance (NCQA)
- State mental health department
- SAMHSA certification for opioid treatment program (OTP)
- Drug Enforcement Agency (DEA)
- Smoking permitted in designated area
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
External Source of Medications Used for Alcohol Use Disorder Treatment
Transitional Services
Recovery Support Services
Payment Assistance Available
Other Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Operation (e.g., Private, Public)
Payment/Insurance/Funding Accepted
Ancillary Services
Medical Services
Age Groups Accepted
Type of Care
Gender Accepted
Treatment Approaches
Pharmacotherapies
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
Education and Counseling Services
Type of Opioid Treatment
Testing
Assessment/Pre-treatment
Special Programs/Groups Offered
Language Services
Opioid Medications used in Treatment
License/Certification/Accreditation
Facility Smoking Policy
External Opioid Medications Source
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm